Scienture Holdings, Inc. (SCNX) Stock Price, Financials & Summary

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$3.29

From 52W high−63.11%

Volume633.00

Market cap$5.65M

P/E (TTM)—

P/S (TTM)6.9x

Div yield—

Key dataNov 4, 2026

Open

$3.29

From 52W high

−63.11%

Volume

633.00

Market cap

$5.65M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.2x

P/E (TTM)

—

RSI (14)

38.7

MomentumView details →

1D Return

−0.34%

YTD Return

+517.65%

SummaryUpdated Jun 1, 2026

Scienture Holdings, Inc. (NASDAQ:SCNX) is a healthcare information technology company founded in 2014 and headquartered in Tampa, Florida. The company operates under the brand name TRxADE HEALTH and has evolved from its original focus on pharmaceutical marketplace services to become a broader healthcare IT solutions provider. Since going public in February 2014, the company has undergone significant strategic pivots and faces ongoing operational challenges while pursuing growth in the digital healthcare sector.

Ask drillr about Scienture Holdings, Inc. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−0.2x

EV/Sales

9.9x

P/S (TTM)

6.9x

P/B (TTM)

0.1x

ProfitabilityView details →

Gross Margin

30.73%

Net Margin

−4620.92%

EBITDA Margin

−4339.11%

ROE (TTM)

−59.21%

ROA (TTM)

−43.26%

Asset Turnover

0.01x

GrowthView details →

Revenue YoY

+540.64%

EPS YoY

—

FCF YoY

−8.57%

Revenue CAGR 3Y

−65.21%

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−0.34%

YTD Return

+517.65%

1Y Return

+284.99%

RSI (14)

38.7

vs 50D SMA

−37.90%

vs 200D SMA

+100.45%

Capital & dividendView details →

Debt/Equity

0.17x

Current Ratio

3.04x

Quick Ratio

2.97x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.07

EPS Surprise

22.22%

Beats (12Q)

2/12

Next Q EPS Est

−$0.37

Avg Surprise (4Q)

−351.47%

Rev Surprise

−82.50%

Financials snapshotView financials →

Revenue (TTM)

821315.00

Net Income (TTM)

−37.95M

Op. CF (TTM)

−14.44M

Next earningsNov 11, 2026 →

Latest newsMore news →

Scienture Holdings, Inc. reported unaudited preliminary Q3 2026 revenue of approximately $1.22 million, up 256% sequentially.22d ago

Scienture Holdings, Inc. announced a 1-for-25 reverse stock split of its common stock, expected to take effect before markets open on October 5, 2026, reducing shares outstanding from 41,064,146 to approximately 1,642,565.35d ago

Similar companies

Aclarion, Inc.ACON Mangoceuticals, Inc.MGRX Zhongchao Inc.ZCMD Healthcare Triangle, Inc.HCTI Bullfrog AI Holdings, Inc. Common StockBFRG MSP Recovery, Inc.MSPRW Find similar companies →

Latest newsMore news →

Scienture Holdings, Inc. reported unaudited preliminary Q3 2026 revenue of approximately $1.22 million, up 256% sequentially.22d ago Scienture Holdings, Inc. announced a 1-for-25 reverse stock split of its common stock, expected to take effect before markets open on October 5, 2026, reducing shares outstanding from 41,064,146 to approximately 1,642,565.35d ago